Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19. (journals.asm.org)

Authors: Rodriguez L … Hedskog C Journal: Antimicrobial Agents and Chemotherapy Published: 2026-07-10 DOI: https://doi.org/10.1128/aac.01912-25